Agilysys Inc. (AGYS) Jumps 10.42% on February 03

Equities Staff |

Agilysys Inc. (AGYS) was among the biggest gainers on the Russell 2000 for Wednesday February 03 as the stock popped 10.42% to $9.96, representing a gain of $0.94 per share. Some 39,772 shares traded hands on 278 trades, compared with an average daily volume of 41,774 shares out of a total float of 22.94 million. The stock opened at $9.90 and traded with an intraday range of $10.00 to $9.32.

After today's gains, Agilysys Inc. reached a market cap of $228.49 million. Agilysys Inc. has had a trading range between $12.56 and $7.97 over the last year, and it had a 50-day SMA of $10.13 and a 200-day SMA of $10.07.

Agilysys Inc provides software for point-of-sale, property management, inventory and procurement, workforce management, analytics, document management and mobile and wireless solutions and services to the hospitality industry.

Agilysys Inc. is based out of Cincinnati, OH and has some 504 employees. Its CEO is James H. Dennedy.

For a complete fundamental analysis analysis of Agilysys Inc., check out Equities.com’s Stock Valuation Analysis report for AGYS. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.